Director/PDMR Shareholding

RNS Number : 8669G
Judges Scientific PLC
12 May 2014
 

Judges Scientific plc (the "Company")

 

12 May 2014

 

 

Director/PDMR Shareholding

 

Judges Scientific has been advised that purchases of Ordinary Shares of 5p each in the Company ("Ordinary Shares") were made on 9 May 2014 by the Trustees of the Share Incentive Plan on behalf of three Directors of the Company, as follows:

 

A total of six Ordinary Shares were purchased on behalf of David Cicurel, the Chief Executive Officer of the Company, to which the Company added a further six Ordinary Shares under the "matching" provisions of the Plan rules.  His resulting interest in the Company is 916,422 Ordinary Shares representing 15.50 per cent of the issued Ordinary share capital.  In addition, he holds options over 1,775 Ordinary Shares under the Company's Share Option Plans.

 

A total of 82 Ordinary Shares were purchased on behalf of David Barnbrook, a Director and the Chief Operating Officer of the Company, to which the Company added a further 27 Ordinary Shares under the "matching" provisions of the Plan rules.  His resulting interest in the Company is 22,490 Ordinary Shares representing 0.38 per cent of the issued Ordinary share capital.  In addition, he holds options over 28,325 Ordinary Shares under the Company's Share Option Plans.

 

A total of seven Ordinary Shares were purchased on behalf of Ralph Cohen, the Finance Director of the Company, to which the Company added a further seven Ordinary Shares under the "matching" provisions of the Plan rules.  His resulting interest in the Company is 57,943 Ordinary Shares representing 0.98 per cent of the issued Ordinary share capital.  In addition, he holds options over 7,875 Ordinary Shares under the Company's Share Option Plans.

 

The purchases by the Trustees were made at a price of 2182.00p per Ordinary Share.  Purchases of a further 774 Ordinary Shares were made on the same date and at the same price on behalf of 66 other members of staff under the Plan.

 

 

 

For further information please contact:

Judges Scientific plc

David Cicurel, CEO

Tel: 01342 323 600

 

Shore Capital (Nominated Adviser & Broker)

Pascal Keane

Edward Mansfield

Tel: 020 7408 4090

 

Cardew Group (Financial Public Relations)

Melvyn Marckus

Tel: 020 7930 0777  or 07775 896 491

 

 

Website:

Judges Scientific: www.judges.uk.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBDGDUSUBBGSD
UK 100

Latest directors dealings